# Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants

> **NCT00480324** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 765 (actual)

## Conditions studied

- Infections, Rotavirus
- Rotavirus Vaccines

## Interventions

- **BIOLOGICAL:** Rotarix
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00480324
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06-19
- **Primary completion:** 2009-03-31
- **Final completion:** 2009-11-21
- **Target enrollment:** 765 (ACTUAL)
- **Last updated:** 2020-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480324, "Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00480324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*